Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Vogel

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 13, 2023
A Call for an Evidence-Based Strategy Against the Overdose CrisisR Michael Krausz, Jean N Westenberg, Andy M Y Tai, et al.
Addiction Science & Clinical Practice|February 13, 2021
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trialJames S H Wong, Mohammadali Nikoo, Jean N Westenberg, et al.
International Journal of Methods in Psychiatric Research|February 5, 2019
Comparing opium tincture and methadone for medication-assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double-blind randomized controlled trialMohammadali Nikoo, Ehsan Moazen-Zadeh, Nooshin Nikoo, et al.
Harm Reduction Journal|January 7, 2023
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational studyMarc Vogel, Maximilian Meyer, Jean N Westenberg, et al.
Science Translational Medicine|April 2, 2025
Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trialBaltazar Gomez-Mancilla, Kenneth M Dürsteler, Marc Vogel, et al.
Molecular Neurobiology|March 14, 2026
NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmaciesMaximilian Meyer, C Felix Mosandl, Adrian Guessoum, et al.
Addiction (Abingdon, England)|August 16, 2022
Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trialMohammadali Nikoo, Kiana Kianpoor, Nooshin Nikoo, et al.
Addiction Science & Clinical Practice|March 14, 2026
24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart reviewPouya Azar, Victor W Li, Mohammadali Nikoo, et al.
Medicina (Kaunas, Lithuania)|April 23, 2022
Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among YouthMichael Krausz, Jean N Westenberg, Vivian Tsang, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 13, 2023
A Call for an Evidence-Based Strategy Against the Overdose CrisisR Michael Krausz, Jean N Westenberg, Andy M Y Tai, et al.
Addiction Science & Clinical Practice|February 13, 2021
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trialJames S H Wong, Mohammadali Nikoo, Jean N Westenberg, et al.
International Journal of Methods in Psychiatric Research|February 5, 2019
Comparing opium tincture and methadone for medication-assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double-blind randomized controlled trialMohammadali Nikoo, Ehsan Moazen-Zadeh, Nooshin Nikoo, et al.
Harm Reduction Journal|January 7, 2023
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational studyMarc Vogel, Maximilian Meyer, Jean N Westenberg, et al.
Science Translational Medicine|April 2, 2025
Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trialBaltazar Gomez-Mancilla, Kenneth M Dürsteler, Marc Vogel, et al.
Molecular Neurobiology|March 14, 2026
NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmaciesMaximilian Meyer, C Felix Mosandl, Adrian Guessoum, et al.
Addiction (Abingdon, England)|August 16, 2022
Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trialMohammadali Nikoo, Kiana Kianpoor, Nooshin Nikoo, et al.
Addiction Science & Clinical Practice|March 14, 2026
24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart reviewPouya Azar, Victor W Li, Mohammadali Nikoo, et al.
Medicina (Kaunas, Lithuania)|April 23, 2022
Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among YouthMichael Krausz, Jean N Westenberg, Vivian Tsang, et al.
Pageof 10